IPSEN : Innovation for patient care

  • Home
  • Our Products
  • Disease Areas
  • Sponsorship
  • The Ipsen Fund
  • Library
  • Contact us

Innovation for patient care

Intended audience: General Public

Focus

About Ipsen Limited

Ipsen Limited is the UK subsidiary of Ipsen, a European pharmaceutical group with over 20 products on the market and a total worldwide staff of nearly 4,200.


Ipsen Limited's Endocrinology and Oncology Business Unit is responsible for a portfolio of products including Decapeptyl® (triptorelin), Increlex® (mecasermin), NutropinAq® (somatropin), Somatuline® (lanreotide) Autogel®, and Somatuline® (lanreotide) LA.


The Neurology Business Unit is responsible for Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

Zoom

Ipsen BSPED Nurse Prize

Ipsen BSPED Nurse Prize

The Ipsen BSPED Paediatric Endocrine Nurse Award has been established to acknowledge, recognise and reward paediatric endocrine nurses for specific projects, or an aspect of their work that raises the standard of nursing practice and healthcare in the UK.

For entry details and form click here

Our Products

All our products

Search
Career Area